Testing for erbB-2 by Immunohistochemistry in Breast Cancer

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Association of C‐<i>erb</i>B‐2 protein over‐expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long‐term survival in breast cancer1991 · 348 citations
2. 2erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer1998 · 654 citations
3. 3HER-2/neu Protein Expression in Breast Cancer Evaluated by Immunohistochemistry2000 · 111 citations
4. 4c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.1996 · 409 citations
5. 5Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers1996 · 759 citations